Display options
Share it on

BMC Hematol. 2014 Mar 25;14(1):8. doi: 10.1186/2052-1839-14-8.

Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naïve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: a comparative cross-sectional study.

BMC hematology

Bamlaku Enawgaw, Meseret Alem, Zelalem Addis, Mulugeta Melku

Affiliations

  1. Department of Hematology & Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, P,O, Box 196, Gondar, Ethiopia. [email protected].

PMID: 24666771 PMCID: PMC3994311 DOI: 10.1186/2052-1839-14-8

Abstract

BACKGROUND: Anemia, leucopenia and thrombocytopenia are the commonest hematological abnormalities resulting from human immunodeficiency virus infection. The use of antiretroviral drugs could positively or negatively affect these disorders. Thus a specific diagnosis and a determination of hematological and immunological parameters are required for initiating and monitoring early treatment to avert disease progression. Therefore, this study aimed to compare hematological and immunological parameters in HIV positive patients taking antiretroviral therapy and those treatment naïve patients in Gondar University Hospital.

METHODS: A comparative cross-sectional study was conducted on a total of 290 HIV patients from February to May 2012 in Gondar University Hospital. Study subjects were divided in to two groups: 145 HIV positive treatment naïve and 145 on HAART. Data of socio demographic characteristics and clinical conditions of the study subjects was collected using structured pretested questionnaire at their follow up date. Hematological and immunological parameters were collected and processed by cell Dyne 1800 and BD FACS count respectively. The variables compared here were Hematological parameters (Total and differential WBC, RBC, Hgb, HCT, MCV, MCH, MCHC, RDW, PLT, and MPV) and CD4 count. In order to compare means independent sample T-test was conducted using SPSS version 20 statistical software. P- Value < 0.05 was considered as significant.

RESULT: Prevalence of anemia, leucopenia, thrombocytopenia, neutropenia and lymphopenia were 11.7%, 35.9%, 4.1%, 28.3% and 2.1% in patients on HAART and 29.7%, 16.6%, 9%, 14.5% and 2.1% in HAART naïve patients respectively. There was a significant difference in total WBC, RBC, Hgb, MCV, MCH, MCHC, MPV and CD4 counts between patients on HAART and HAART naïve patients.

CONCLUSION: Prevalence of anemia was high in HAART naïve patients while leucopenia and neutropenia prevalence was higher in patients on HAART and their prevalence increased as the CD4 count decreased. HIV Patients should be investigated for hematological and immunological changes following with appropriate therapeutic interventions.

References

  1. BMC Blood Disord. 2009 Aug 13;9:5 - PubMed
  2. J Infect Dis. 2002 May 15;185 Suppl 2:S110-4 - PubMed
  3. Autoimmun Rev. 2011 Dec;11(2):88-97 - PubMed
  4. Afr Health Sci. 2011 Mar;11(1):2-15 - PubMed
  5. Am J Med. 2004 Apr 5;116 Suppl 7A:27S-43S - PubMed
  6. AIDS Res Hum Retroviruses. 2005 Mar;21(3):200-6 - PubMed
  7. Afr J Med Med Sci. 2006 Dec;35 Suppl:85-91 - PubMed
  8. Ethiop Med J. 2012 Jan;50(1):13-21 - PubMed
  9. Int J STD AIDS. 2009 Jul;20(7):489-92 - PubMed
  10. Indian J Pathol Microbiol. 2002 Apr;45(2):147-50 - PubMed
  11. Int J Infect Dis. 2011 Dec;15(12):e808-11 - PubMed
  12. AIDS. 2003 Jan 3;17(1):119-21 - PubMed
  13. Hematology Am Soc Hematol Educ Program. 2008;:212-8 - PubMed
  14. Blood. 1993 May 15;81(10):2664-70 - PubMed
  15. Br J Haematol. 1997 Oct;99(1):1-8 - PubMed
  16. J Acquir Immune Defic Syndr. 2001 Nov 1;28(3):221-5 - PubMed
  17. Curr Med Res Opin. 2007 Feb;23(2):343-55 - PubMed
  18. BMC Hematol. 2013 Aug 09;13(1):8 - PubMed
  19. Niger J Med. 2005 Jan-Mar;14(1):33-8 - PubMed

Publication Types